Ulf Tossman, chairman of the board of Isconova, comments;
”Lena has made great strides during her time as CEO. Under her management, Isconova has taken several important steps through the implemented strategy change with an increased focus on human vaccines, the listing on First North as well as the agreements made within both human and veterinary vaccines. Going forward, the board’s assessment is that the company needs leadership with significant international experience and a strong track record in business development, and so a search is now underway to find a CEO with these specific skills. “
Russell Greig has more than 30 years experience in different positions within the pharmaceutical industry, most recently as President of SR One, GlaxoSmithKline’s Corporate Venture Group. During his years at GSK, Russell’s roles included Senior Vice President of Worldwide Business Development, General Manager of UK Pharmaceuticals and President of Pharmaceutical International.
For more information, please contact:
Ulf Tossman, chairman of the board of Isconova
Tel: +46 (0)705-63 08 58, e-mail: ulf.tossman@innkap.se
Russell Greig, acting CEO Isconova
Tel: + 1 610 220 9802, e-mail: russell.greig@gmail.com
Lena Söderström, CEO Isconova
Tel: +46 (0)708-16 39 12, e-mail: lena.soderstrom@isconova.com
About Isconova
Isconova AB is a leading international vaccine adjuvant company. Isconova has vast knowledge of vaccine systems and the company develops vaccines together with partners in the human and veterinary markets. The first vaccine using Isconovas nano-particle Matrix technology, Equilis®Prequenza, was launched on the veterinary market in 2005. In the human market a number of vaccines are under development with Isconova’s third generation nano-particle, Matrix MTM. Isconova’s partners include Johnson& Johnson/Crucell, Pfizer, Merck & Co., The Jenner Institute, Genocea and Evolva. The Company is headquartered in Uppsala, Sweden.
Isconova was listed on NASDAQ OMX First North (ticker: ISCO) in November 2010. E. Öhman J:or AB is the Company’s Certified Adviser. www.isconova.com
